Mebendazole belongs to the benzimidazole class of antiparasitic agents. It inhibits tubulin synthesis in parasite cells, leading to impaired glucose uptake, depletion of energy stores, and eventual parasite death.
Recommended for:
The efficacy and safety of mebendazole are supported by extensive clinical studies and decades of medical use. It is included in international treatment guidelines and demonstrates activity against various nematodes and certain cestodes at different life stages.
Indicated for the treatment of helminth infections caused by parasites sensitive to mebendazole. Used to eliminate parasites, reduce clinical symptoms, and restore normal gastrointestinal function by disrupting essential metabolic processes in parasite cells.
Administered orally, usually with or after meals. Dosage and treatment duration should be determined by a healthcare professional based on the type of infection and the patient’s condition.
Contraindications
Side Effects
